The Bioavailability Toolbox

Summary:
Since the advent of combinatorial chemistry and high-throughput screening in the 1990s, bioavailability challenges have become more and more complex. In response, new formulations and delivery methods have emerged. The result, scientists now have an arsenal of techniques to choose from. “It used to be that micronization and the particleforming step were all that you had, but now with the different formulation options, scientists have a much greater chance of improving bioavailability,” says David Igo, Director of Product Development and Manufacturing at Catalent Pharma Solutions.